MK-0677 (ibutamoren mesylate) for the treatment of patients recovering from hip fracture: a multicenter, randomized, placebo-controlled phase IIb study.

[1]  H. Handoll,et al.  Multidisciplinary rehabilitation for older people with hip fractures. , 2009, The Cochrane database of systematic reviews.

[2]  M. Thorner.  Statement by the Growth Hormone Research Society on the GH/IGF-I axis in extending health span. , 2009, The journals of gerontology. Series A, Biological sciences and medical sciences.

[3]  Emma Smith,et al.  Methodology and baseline characteristics for the Sarcopenia and Hip Fracture study: a 5-year prospective study. , 2009, The journals of gerontology. Series A, Biological sciences and medical sciences.

[4]  A. Hoffman,et al.  Effects of an oral growth hormone secretagogue in older adults. , 2009, The Journal of clinical endocrinology and metabolism.

[5]  A. Jette,et al.  Performance-based or self-report measures of physical function: which should be used in clinical trials of hip fracture patients? , 2008, Archives of physical medicine and rehabilitation.

[6]  J. Schertzer,et al.  Cellular and molecular mechanisms underlying age-related skeletal muscle wasting and weakness , 2008, Biogerontology.

[7]  A. Jette,et al.  Interpreting rehabilitation outcome measurements. , 2007, Journal of rehabilitation medicine.

[8]  Walter R Frontera,et al.  Is stair climb power a clinically relevant measure of leg power impairments in at-risk older adults? , 2007, Archives of physical medicine and rehabilitation.

[9]  R. Craik,et al.  Determining meaningful changes in gait speed after hip fracture. , 2006, Physical therapy.

[10]  S. Studenski,et al.  Meaningful Change and Responsiveness in Common Physical Performance Measures in Older Adults , 2006, Journal of the American Geriatrics Society.

[11]  K. Schroeder,et al.  Interventions for sarcopenia and muscle weakness in older people. , 2005, Age and ageing.

[12]  Catherine Sherrington,et al.  Reliability of simple portable tests of physical performance in older people after hip fracture , 2005, Clinical rehabilitation.

[13]  M. E. Cress,et al.  Continuous-scale physical functional performance test: validity, reliability, and sensitivity of data for the short version. , 2005, Physical therapy.

[14]  Yuxiang Sun,et al.  Growth hormone secretagogues: prospects and potential pitfalls. , 2004, Best practice & research. Clinical endocrinology & metabolism.

[15]  C. Zetterberg,et al.  The Effects of MK‐0677, an Oral Growth Hormone Secretagogue, in Patients with Hip Fracture , 2004, Journal of the American Geriatrics Society.

[16]  S. Studenski,et al.  Designing Randomized, Controlled Trials Aimed at Preventing or Delaying Functional Decline and Disability in Frail, Older Persons: A Consensus Report , 2004, Journal of the American Geriatrics Society.

[17]  M. Kosinski,et al.  Score comparability of short forms and computerized adaptive testing: Simulation study with the activity measure for post-acute care. , 2004, Archives of physical medicine and rehabilitation.

[18]  S. J. Sinclair,et al.  Activity Outcome Measurement for Postacute Care , 2004, Medical care.

[19]  K. Nair,et al.  Sarcopenia—consequences, mechanisms, and potential therapies , 2003, Mechanisms of Ageing and Development.

[20]  E. Hannan,et al.  Patients with Hip Fracture: Subgroups and Their Outcomes , 2002, Journal of the American Geriatrics Society.

[21]  Jonathan F. Bean,et al.  Muscle Power of the Ankle Flexors Predicts Functional Performance in Community‐Dwelling Older Women , 2001 .

[22]  V. Hughes,et al.  Sarcopenia: current concepts. , 2000, The journals of gerontology. Series A, Biological sciences and medical sciences.

[23]  Suzanne G. Leveille,et al.  Lower extremity performance in nondisabled older persons as a predictor of subsequent hospitalization. , 2000, The journals of gerontology. Series A, Biological sciences and medical sciences.

[24]  A. Kramer,et al.  Outcomes of Older Persons Receiving Rehabilitation for Medical and Surgical Conditions Compared with Hip Fracture and Stroke , 2000, Journal of the American Geriatrics Society.

[25]  R. Ross,et al.  Skeletal muscle mass and distribution in 468 men and women aged 18-88 yr. , 2000, Journal of applied physiology.

[26]  D M Buchner,et al.  Exercise: effects on physical functional performance in independent older adults. , 1999, The journals of gerontology. Series A, Biological sciences and medical sciences.

[27]  S. Heymsfield,et al.  Epidemiology of sarcopenia among the elderly in New Mexico. , 1998, American journal of epidemiology.

[28]  E. van Cauter,et al.  Stimulation of the growth hormone (GH)-insulin-like growth factor I axis by daily oral administration of a GH secretogogue (MK-677) in healthy elderly subjects. , 1996, The Journal of clinical endocrinology and metabolism.

[29]  L. Ferrucci,et al.  A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. , 1994, Journal of gerontology.

[30]  C. McHorney,et al.  The MOS 36‐Item Short‐Form Health Survey (SF‐36): II. Psychometric and Clinical Tests of Validity in Measuring Physical and Mental Health Constructs , 1993, Medical care.

[31]  R A Marottoli,et al.  Decline in Physical Function following Hip Fracture , 1992, Journal of the American Geriatrics Society.

[32]  C. Sherbourne,et al.  The MOS 36-Item Short-Form Health Survey (SF-36) , 1992 .

[33]  R. McCARTER,et al.  The influence of age on the 24-hour integrated concentration of growth hormone in normal individuals. , 1985, The Journal of clinical endocrinology and metabolism.

[34]  S. Z. Nagi.  An epidemiology of disability among adults in the United States. , 1976, The Milbank Memorial Fund quarterly. Health and society.

[35]  G. Lynch.  Update on emerging drugs for sarcopenia - age-related muscle wasting. , 2008, Expert Opinion on Emerging Drugs.

[36]  Tamara B Harris,et al.  Strength, but not muscle mass, is associated with mortality in the health, aging and body composition study cohort. , 2006, The journals of gerontology. Series A, Biological sciences and medical sciences.

[37]  O. Johnell,et al.  World-wide Projections for Hip Fracture , 1997, Osteoporosis International.

[38]  A M Jette,et al.  The disablement process. , 1994, Social science & medicine.